China Health Group Limited

Sümbol: 0673.HK

HKSE

1.08

HKD

Turuhind täna

  • -7.6033

    P/E suhe

  • 0.1324

    PEG suhe

  • 517.31M

    MRK Cap

  • 0.00%

    DIV tootlus

China Health Group Limited (0673-HK) Finantsaruanded

Diagrammil näete China Health Group Limited (0673.HK) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Bilanss

Sukeldudes China Health Group Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

011.58.54.6
10.2
30.2
44.2
7.3
205
99.1
53.1
4.3
32.5
172.2
174.1
156.5
59.7
74.4
47.9
47.3
71.4
4.2
11.7

balance-sheet.row.short-term-investments

06.20.50.5
0.6
0.2
5.2
0.3
0
2.5
32.1
39.5
0
0
0
0.1
0.1
0.3
0
0
0
0
0.1

balance-sheet.row.net-receivables

090110.6150.2
127.4
32.8
19.7
1.7
0.6
76.2
55.3
28.3
0
0
0
0
0
0
0
0
0
0
44.3

balance-sheet.row.inventory

011.713.45.1
6.6
0.2
0.2
0
0
0
-55.3
-28.3
0
3
22.7
26.5
14.5
23.3
2.6
3.4
2.2
46.2
41.9

balance-sheet.row.other-current-assets

0295.14.6
0.7
93.9
41.9
49.8
11.2
98.5
153.5
230.5
219.3
107.6
55
54.8
75.4
47.2
19.1
28.4
47.5
76.2
10

balance-sheet.row.total-current-assets

0142.1137.7164.5
144.9
157.1
106
58.9
216.8
273.8
206.6
234.8
251.8
282.8
251.8
237.8
149.6
144.9
69.7
79.1
121.1
126.7
107.8

balance-sheet.row.property-plant-equipment-net

02428.830.8
29.3
0.3
1.3
1.5
0.2
0.1
0.5
1.6
1.6
5
8.5
10.9
12
15.9
12
6.9
0.6
4.2
8.7

balance-sheet.row.goodwill

037.94122.6
22.6
0
0
0
0
0.7
0.7
0
0
0
32.6
31.4
27.2
30.9
23.9
0
13.3
0
0

balance-sheet.row.intangible-assets

037.94122.6
22.6
14.7
17.1
16.5
0
0
0
50.5
0
1.3
2
0.6
0.8
1.9
1.1
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

075.881.945.2
45.2
14.7
17.1
16.5
0
0.7
0.7
50.5
0
1.3
34.6
32
28
32.8
25
39.4
13.3
0
0

balance-sheet.row.long-term-investments

0000
0
43.2
100.9
22.6
18
0
-30.6
-37.4
0
0
0
-0.1
-0.1
-0.3
0
0
0
0
28.4

balance-sheet.row.tax-assets

0000
0
-28.1
-82.6
0
0
0
30.6
37.4
0
0
0
0
0.1
0.3
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0-20.7-22.4-22.6
-22.6
-15
-18.3
-40.6
-18
-0.8
33.7
42.8
4.2
0
0
0.1
6.9
5.3
0
22.6
23.3
60.2
22.2

balance-sheet.row.total-non-current-assets

07988.353.4
51.9
15
18.3
40.6
0.2
0.8
4.3
57.5
5.8
6.4
43.1
42.9
46.9
53.9
37
68.9
37.2
64.4
59.3

balance-sheet.row.other-assets

0000
0
43.2
100.9
70.7
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0221.2226217.8
196.8
215.2
225.3
170.1
235
274.6
210.9
292.3
257.6
289.2
294.9
280.6
196.4
198.8
106.7
148
158.3
191.1
167.2

balance-sheet.row.account-payables

024.121.117.1
14.1
4.4
0.1
55.5
49.9
10.3
13.9
6.2
0.1
0.1
2.1
0.8
2.2
0.6
1.4
1
4.1
66.3
43.3

balance-sheet.row.short-term-debt

0618.54.6
1.3
40.8
0
0
0
59.8
50.6
66.1
8.1
0
263.2
53.4
0
0
0
17.3
0.1
8.3
44.3

balance-sheet.row.tax-payables

01.63.92.3
6.4
5.7
2.7
0
0
3.3
2.9
3.2
2.3
3.5
0.2
0.2
0.8
0.3
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0000.7
1.9
0
60
60
225
0
0
0
0
0
0
0
62.2
66.6
0
0
20.5
6.1
9.9

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

091.695.994.7
76.4
78.8
64.1
4.6
4.7
167.9
130.7
219.9
328.4
160.6
50.8
100.9
86
76.8
19.2
14.5
11.1
50.4
33.4

balance-sheet.row.total-non-current-liabilities

003.90.7
1.9
0
60
60
225
0
0
0
0
226.3
0.4
0
152.8
147.8
49
0
20.5
6.1
9.9

balance-sheet.row.other-liabilities

0000
0
0
-60
-60
-225
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

00.40.80.7
1.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
7
12.7

balance-sheet.row.total-liab

0127.2140.8117.8
96.1
83.2
64.2
60.1
54.6
238
311.4
295.4
375.7
387
316.7
224.7
241
225.1
69.6
32.7
35.7
131.1
125.6

balance-sheet.row.preferred-stock

0000
0
0
0
2.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0471.8414414
414
409.4
364
322
212
68.3
63.3
60.3
50.3
50.3
26.2
23.4
0
0
0
21.7
20
10
51.4

balance-sheet.row.retained-earnings

0-958.5-916.6-904.9
-897.3
-869.2
-842.7
-803.4
-735.8
-665.1
-610.3
-542.7
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

00-0.92.8
-2.8
7.1
16.7
-2.2
0.5
0
-2.1
-2.3
-1.2
-5.3
-16.2
-13.1
0
0
0
-2.1
-1.8
-68.9
-133

balance-sheet.row.other-total-stockholders-equity

0573.1583.1583.1
583.1
583.1
623.1
593.7
703.7
605
448.5
481.6
-285.3
-263.8
-122.8
-53.7
-57.6
-39.1
31.5
87
104
118.9
123.1

balance-sheet.row.total-stockholders-equity

086.379.695
97
130.4
161.1
110
180.4
8.2
-100.5
-3.1
-236.1
-218.8
-112.8
-43.4
-57.6
-39.1
31.5
106.6
122.2
60
41.6

balance-sheet.row.total-liabilities-and-stockholders-equity

0221.2226217.8
196.8
215.2
225.3
170.1
235
274.6
210.9
292.3
257.6
289.2
294.9
280.6
196.4
198.8
106.7
148
158.3
191.1
167.2

balance-sheet.row.minority-interest

07.65.64.9
3.8
1.6
0
0
0
28.4
41.1
81.1
118.1
121
90.9
99.4
13
12.7
5.6
8.7
0.5
0
0

balance-sheet.row.total-equity

09485.1100
100.7
132
161.1
110
180.4
36.6
-59.5
78
-118.1
-97.8
-21.8
56
-44.6
-26.3
37.1
115.2
122.6
60
41.6

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

06.20.50.5
0.6
0.2
5.2
22.8
18
2.5
1.6
2.1
0
0
0
0
0
0
0
22.6
23.3
39
28.5

balance-sheet.row.total-debt

0618.55.4
3.1
40.8
60
60
225
59.8
50.6
66.1
8.1
0
263.2
53.4
62.2
66.6
0
17.3
20.5
14.4
54.2

balance-sheet.row.net-debt

0-5.49.90.8
-7.1
10.8
21
52.9
20
-36.8
-2.5
61.8
-24.4
-172.2
89
-103.1
2.6
-7.4
-47.9
-30
-50.9
10.2
42.7

Rahavoogude aruanne

China Health Group Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

cash-flows.row.net-income

0-42-12.2-7.7
-36.7
-23.1
-39.2
-69.3
-73.2
-55.9
-108.1
140.6
-21.6
-178.8
-98.4
28.5
-24
-74.3
-101.9
-53.1
-49.7
-59.6
-31.1

cash-flows.row.depreciation-and-amortization

04.243.6
2.5
1.7
1.4
0.6
0.1
0.5
9.9
4.3
2.1
4.5
4.7
5.9
5.8
5.2
2.8
4.7
3.3
3.1
5.1

cash-flows.row.deferred-income-tax

0-26.639.1-24.5
-24.5
0
13.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

000.80.9
9.9
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

010.137.22.5
-10
-16.9
-17.1
-1.2
-11.3
-20.6
51.7
11.9
-82.3
-19.4
2.8
-16.3
7.8
-32.7
5.1
35.2
-3.5
0.3
10.5

cash-flows.row.account-receivables

08.349.7-20.9
-2.2
-17
-16.9
-1.2
-11.3
-20.6
-26.6
-1.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

01.8-1.71.5
-6.6
0
-0.2
0
3.6
0
0
0
1.1
0
3.6
-13
7.2
-12.8
0.4
1.4
6.5
-4.3
-2.7

cash-flows.row.account-payables

00-0.13
-0.8
4.3
0.1
0
-1.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-10.818.9
-0.5
-4.3
-0.1
0
1.3
0
78.2
13
-83.4
0
-0.8
-3.3
0.6
-19.9
4.7
33.9
-9.9
4.6
13.2

cash-flows.row.other-non-cash-items

046.2-37.116.2
37
21
0
-36
23.5
61.2
71.4
-171.6
-21
167.8
69.7
-45.8
-11.8
40.3
56
8.7
4.1
29
31.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1.4-0.8-1.8
-0.4
0
-0.3
-13.5
-0.3
-0.1
0
-1.5
-2.7
0
-1.9
-4.4
-8.3
-1.6
-5.9
-5.7
-0.1
-0.2
-5.6

cash-flows.row.acquisitions-net

0-4-160
-1.3
1.6
-17.1
0
-13.6
0
0.1
0
-40.1
-2.2
-0.9
-26.2
13.9
-1.5
0
-47.9
-11.3
1
0

cash-flows.row.purchases-of-investments

00-18.50
0
0
-5.3
-22.6
11.4
-1.9
0
0
0
0
0.9
0
0
0
0
0
-11.6
-16
-37

cash-flows.row.sales-maturities-of-investments

0018.50
0
0
22.4
0
2.3
0
0
0
0
0
0.2
0
0
0
0
0
11.6
1.1
7

cash-flows.row.other-investing-activites

00-18.50
0
-1
-6.1
-57.4
-16.9
0.3
0.1
0.1
1
-2.7
-0.2
10.4
-5.7
-19.6
-7
0.8
15.3
-18.6
-46.2

cash-flows.row.net-cash-used-for-investing-activites

0-5.4-35.3-1.8
-1.7
0.5
-6.3
-93.4
-28.6
-1.7
0.2
-1.4
-41.8
-4.9
-1.9
-20.2
0
-22.7
-12.8
-52.7
3.8
-32.6
-81.8

cash-flows.row.debt-repayment

0-18.1-14.1-3.6
-0.7
0
0
0
-43.2
0
0
0
-84.8
-34.8
0
-63
0
0
0
-1.9
-5.5
-36.2
-84.9

cash-flows.row.common-stock-issued

0000
4.6
5.4
71.4
0
38.3
10.6
0
0
0
0
0
0
0
0
0
33.1
72.2
77
95.7

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
17.9
-116.2
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
-13
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

045.8276.2
0
1.6
-0.2
0
217
197
-10.6
0.5
93.9
62.9
38.6
207.2
1.3
108
51.3
1.8
42.3
11.6
100.8

cash-flows.row.net-cash-used-provided-by-financing-activities

027.7132.6
3.9
7
71.2
0
199.2
91.4
-10.6
0.5
9.2
28.1
38.6
144.3
1.3
108
51.3
33.1
109.1
52.4
111.6

cash-flows.row.effect-of-forex-changes-on-cash

0-11.1-5.52.6
-0.1
0.7
4.9
1.3
-6
-0.2
-2
-2.7
15.6
0.7
2.2
0.4
6.5
2.2
0.1
0
0
0
0

cash-flows.row.net-change-in-cash

02.93.9-5.7
-19.7
-9.1
31.9
-197.9
103.7
74.7
12.4
-18.2
-139.7
-2
17.7
96.9
-14.4
26.1
0.6
-24.1
67.2
-7.3
46

cash-flows.row.cash-at-end-of-period

011.58.54.6
10.2
29.9
39
7.1
205
101.3
26.7
14.2
32.5
172.2
174.1
156.4
59.6
74
47.9
47.3
71.4
4.2
11.5

cash-flows.row.cash-at-beginning-of-period

08.54.610.2
29.9
39
7.1
205
101.3
26.7
14.2
32.5
172.2
174.1
156.4
59.6
74
47.9
47.3
71.4
4.2
11.5
-34.5

cash-flows.row.operating-cash-flow

0-8.231.8-9.1
-21.8
-17.3
-37.9
-105.8
-60.9
-14.8
24.8
-14.7
-122.7
-25.8
-21.2
-27.6
-22.2
-61.5
-38
-4.4
-45.8
-27.1
16.2

cash-flows.row.capital-expenditure

0-1.4-0.8-1.8
-0.4
0
-0.3
-13.5
-0.3
-0.1
0
-1.5
-2.7
0
-1.9
-4.4
-8.3
-1.6
-5.9
-5.7
-0.1
-0.2
-5.6

cash-flows.row.free-cash-flow

0-9.631-10.9
-22.2
-17.3
-38.1
-119.3
-61.1
-14.9
24.8
-16.2
-125.4
-25.8
-23
-32
-30.5
-63.1
-43.8
-10.1
-45.9
-27.3
10.5

Kasumiaruande rida

China Health Group Limited tulud muutusid võrreldes eelmise perioodiga NaN%. 0673.HK brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

076.410787.9
45.2
32.2
24.2
15
23.7
37.8
37.7
23.1
49.1
78.4
2776.4
2870.7
2867.6
1633
6.8
34.8
222.8
245.4
189.6

income-statement-row.row.cost-of-revenue

049.278.361.9
27.9
16.1
10.5
6
18.2
30.3
27.1
11.1
16.8
41.4
2750.8
2844.5
2841.1
0
0
40.7
225.6
233.2
168.9

income-statement-row.row.gross-profit

027.228.726
17.3
16.1
13.8
9
5.5
7.5
10.6
12.1
32.3
37
25.7
26.2
26.5
1633
6.8
-6
-2.8
12.2
20.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.10.41.3
1.4
0.7
1.2
0
0
0
0
-1.1
-3.1
-3.8
-24.9
85.6
8.4
42.4
107.3
4.4
19.2
19.8
-2.1

income-statement-row.row.operating-expenses

043.542.637.3
44.6
43.8
56.1
80.6
77.6
31.4
46.4
42.8
66
54.1
53.8
40.2
49
84.1
107.3
39.2
59.5
64.3
51.8

income-statement-row.row.cost-and-expenses

092.7120.999.2
72.5
59.9
66.5
86.6
95.8
61.7
73.6
53.9
82.8
95.5
2804.6
2884.7
2890.1
84.1
107.3
79.9
285.1
297.4
220.7

income-statement-row.row.interest-income

00.40.35.1
6.4
7.8
5.6
2.5
6.2
44.4
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

02.20.30.3
0.1
0
0.2
0
7.3
31.1
1.7
127
102.1
102.6
63.9
22.2
0
0
0
0.7
2.5
3.8
17.4

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-19.15.26
-7
8.6
-3
5.2
-23.6
-44
-72.3
160.2
12.6
-164
-70.3
42.5
0.6
-1622.3
-1.4
-8.6
10
-11.3
140.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.10.41.3
1.4
0.7
1.2
0
0
0
0
-1.1
-3.1
-3.8
-24.9
85.6
8.4
42.4
107.3
4.4
19.2
19.8
-2.1

income-statement-row.row.total-operating-expenses

0-19.15.26
-7
8.6
-3
5.2
-23.6
-44
-72.3
160.2
12.6
-164
-70.3
42.5
0.6
-1622.3
-1.4
-8.6
10
-11.3
140.7

income-statement-row.row.interest-expense

02.20.30.3
0.1
0
0.2
0
7.3
31.1
1.7
127
102.1
102.6
63.9
22.2
0
0
0
0.7
2.5
3.8
17.4

income-statement-row.row.depreciation-and-amortization

04.243.6
2.5
1.7
1.4
0.6
0.1
0.5
9.9
4.3
2.1
4.5
4.7
5.9
5.8
5.2
2.8
4.7
3.3
3.1
5.1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-16.3-13.9-11.3
-27.3
-28.5
-33.7
-74.3
-54.7
-24.2
-35.7
-30.6
-33.7
-42.1
-31.9
-40.4
-19.6
-64.6
-99.1
-53.1
-49.7
-59.6
-31.1

income-statement-row.row.income-before-tax

0-35.4-8.7-5.3
-34.3
-19.9
-36.7
-69.1
-78.3
-68.2
-108.1
129.5
-21.1
-181
-98.4
28.5
-21.9
-73.4
-101.9
-53.8
-52.2
-63.4
109.6

income-statement-row.row.income-tax-expense

00.20.41.2
1.4
3.1
2.5
0.2
0.1
0.4
0.6
0.3
2
3.4
0.4
1.5
2.1
0.9
0
-1.8
20.4
0
-1

income-statement-row.row.net-income

0-42-12.2-7.7
-36.7
-23.1
-39.2
-69.3
-73.2
-55.9
-67.6
140.6
-18.6
-208.2
-89.7
12.3
-24
-74.3
-101.9
-51.9
-52
-63.4
110.6

Korduma kippuv küsimus

Mis on China Health Group Limited (0673.HK) koguvara?

China Health Group Limited (0673.HK) koguvara on 221185000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.321.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -0.052.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.535.

Mis on ettevõtte kogutulu?

Kogutulu on -0.300.

Mis on China Health Group Limited (0673.HK) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -42046000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 6037000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 43502000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.